Enhancing study success with advanced clinical research technologies and expert solutions for Multiple Sclerosis trials.
Multiple Sclerosis
Trial Solutions
Effective solutions for advancing Multiple Sclerosis research
Recent scientific advancements have spurred the development and approval of new disease-modifying therapies for multiple sclerosis (MS), but the need for a cure and more effective therapies persists. As one of the earliest enablers of the electronic EDSS (eEDSS), researchers leverage Signant's eCOA expertise as well as our full suite of clinical research technology solutions and scientific services to generate reliable endpoint data.
Why Signant Health
- Capture Better EDSS Data, Faster
- Maximize Supply Efficiency
- Improve Rater Accuracy
- Work with our MS Experts
- Make Participation Easier
- Safeguard Endpoint Data
-
Capture Better EDSS Data, Faster
Capture Better EDSS Data, Faster
Take advantage of our extensively tested electronic EDSS which has proven to increase endpoint data quality, improve clinical reviews, and reduce administration time. For more than ten years, our BYOD-ready eEDSS has set the standard for trouble-free implementation and reliable results. -
Maximize Supply Efficiency
Maximize Supply Efficiency
Our RTSM system helps study teams handle variable dosing schedules and complex medication management requirements for global studies with ease. Our operational and logistics experts help you launch faster, minimize product waste, and implement mid-study amendments efficiently. -
Improve Rater Accuracy
Improve Rater Accuracy
Inconsistencies in assessment scoring and administration can lead to difficulties interpreting the data collected. Signant's Rater Training program focuses on qualifying raters and standardizing assessment technique to reduce inter- and intra-rater variability. We can also create a custom training video tailored to the individual needs of each study for use across sites and programs. -
Work with our MS Experts
Work with our MS Experts
Talk through your MS protocol with our science and medicine experts, who serve as an extension of your study team. We guide the implementation and administration of EDSS and other assessments, recommend methods to decrease site and participant burdens, and ensure your study generates inspection-ready data. -
Make Participation Easier
Make Participation Easier
Simplify the clinical trial experience for patients and sites alike by providing tools like eConsent and Telemedicine. These solutions help reduce unnecessary site visits, improve inter-visit remote collaboration between sites and patients, as well as promote protocol adherence and continued study engagement. -
Safeguard Endpoint Data
Safeguard Endpoint Data
Guide investigative staff through proper ClinRO assessment technique using our enhanced clinician ratings platform. Automated scoring as well as built-in edit checks help reduce errors. When paired with Blinded Data Analytics, we can proactively monitor data in real-time, creating opportunities to mitigate risks before they impact your study data.
Comprehensive Multiple Sclerosis experience
0
STUDIES
0
PATIENTS
0
COUNTRIES
0
SITES
Explore our Multiple Sclerosis trial resources
CASE STUDY
READ CASE STUDY
How an Electronic Version of Neurostatus-EDSS Improved Data Quality in Multiple Sclerosis Studies
eClinical solutions for Multiple Sclerosis trials
Ready to learn more?
Discover how Signant can support your current or upcoming MS trials.